Cargando…
Design and Development of a Novel Vaccine for Protection against Lyme Borreliosis
There is currently no Lyme borreliosis vaccine available for humans, although it has been shown that the disease can be prevented by immunization with an OspA-based vaccine (LYMErix). Outer surface protein A (OspA) is one of the dominant antigens expressed by the spirochetes when present in a tick....
Autores principales: | Comstedt, Pär, Hanner, Markus, Schüler, Wolfgang, Meinke, Andreas, Lundberg, Urban |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4237411/ https://www.ncbi.nlm.nih.gov/pubmed/25409015 http://dx.doi.org/10.1371/journal.pone.0113294 |
Ejemplares similares
-
The novel Lyme borreliosis vaccine VLA15 shows broad protection against Borrelia species expressing six different OspA serotypes
por: Comstedt, Pär, et al.
Publicado: (2017) -
Migratory Passerine Birds as Reservoirs of Lyme Borreliosis in Europe
por: Comstedt, Pär, et al.
Publicado: (2006) -
Complex Population Structure of Lyme Borreliosis Group Spirochete Borrelia garinii in Subarctic Eurasia
por: Comstedt, Pär, et al.
Publicado: (2009) -
Treatment of Lyme borreliosis
por: Girschick, Hermann J, et al.
Publicado: (2009) -
Lyme Borreliosis and Skin
por: Vasudevan, Biju, et al.
Publicado: (2013)